Top 20 Most Heavily Promoted Penny Stocks For May 2012

Pink Sheets
SMAA	SMA Alliance, Inc.
ITNS	ITonis, Inc.
ORYN	Oryon Technologies, Inc.
AXCG	Eyes on the Go, Inc.
HHII	Home Health Internatio...
DIGX	Dig-It Underground, Inc.
VIBE	Vidable Inc
VRAL	Viral Genetics, Inc.
CQPT	Conquest Petroleum Inc.
EXMT	Anything Technologies ...

OTC BB
UAPC	United American Petrol...
GWBU	Great Wall Builders, Ltd.
RACK	Rackwise, Inc.
IDOI	Ido Security Inc
TRON	Toron, Inc.
LUVU	Libertador, Inc.
MDRM	Modern Mobility Aids
PTSH	Pts, Inc
PFNI	Psychic Friends Networ...
SNPK	Sunpeaks Ventures, Inc.

BROWSE COMPANIES

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9

News for Intellect Neurosciences, Inc. (ILNS)

Company

News · Filings

News for Intellect Neurosciences Inc. (ILNS)

Fri, May 18, 2012

9:35 AM

Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference - PR Newswire

Wed, May 16, 2012

9:35 AM

Intellect Neurosciences Expands Its Immunotherapy Pipeline with New Technology Platforms Targeting Pathogenic Protein Aggregates Focused on Huntington's and Parkinson's Diseases - PR Newswire

Tue, May 15, 2012

9:35 AM

Intellect Neurosciences Issues Letter to Shareholders - PR Newswire

Mon, May 07, 2012

9:35 AM

Intellect Neurosciences Adds Two New Tau Programs to its Alzheimer's Disease Development Pipeline - PR Newswire

Tue, Apr 17, 2012

9:15 AM

Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimer's Research Group at University of California Irvine to Test First in Class Dual Target Vaccine - PR Newswire

Tue, Mar 06, 2012

9:00 AM

Important Patent News for Intellect Neurosciences... What's Next? - Marketwire

8:30 AM

Intellect Neurosciences Receives Notice of Allowance from United States Patent and Trademark Office for its ANTISENILIN� Alzheimer's Disease Immunotherapy Technology Platform - PR Newswire

8:30 AM

Intellect Neurosciences Receives Notice of Allowance from United States Patent and Trademark Office for its ANTISENILIN� Alzheimer's Disease Immunotherapy Technology Platform - PR Newswire

Wed, Feb 15, 2012

1:20 AM

Alzheimers and Skin Cancer are hot topics at BioCeo Conference in New York - Accesswire

Tue, Feb 14, 2012

8:35 AM

Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings - PR Newswire

Tue, Feb 07, 2012

8:30 AM

Intellect Neurosciences Files New Patent Applications for Immunotherapy Methods to Target Abnormal Tau Protein in Treatment of Alzheimer's disease - PR Newswire

Thu, Feb 02, 2012

1:44 PM

Intellect Neurosciences Issues Letter to Shareholders - PR Newswire

Tue, Jan 17, 2012

9:35 AM

Intellect Neurosciences, Inc. to Present at BIO Asia International Conference - PR Newswire

Thu, Dec 15, 2011

9:35 AM

Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer - PR Newswire

Wed, Dec 14, 2011

9:35 AM

Intellect Neurosciences, Inc. to Present at OneMedForum - PR Newswire

Tue, Oct 04, 2011

7:00 AM

Intellect Neurosciences CEO to Speak at Phacilitate CNS Leaders Forum Conference - Globe Newswire

Fri, Sep 30, 2011

8:14 AM

Intellect Neurosciences and ViroPharma Announce $126.5 Million Global Licensing Agreement to Develop and Commercialize OX1 for Friedreich's Ataxia and Other Neurodegenerative Diseases - Globe Newswire

Thu, Jul 21, 2011

8:19 AM

Intellect Neurosciences, Inc. Obtains Notice of Allowance for Alzheimer's Beta Amyloid Vaccine from the Japan Patent Office in Relation to the Company's RECALL-VAX(TM) Technology - Globe Newswire

Wed, Sep 15, 2010

9:14 AM

Intellect Neurosciences CEO Predicts �We are Less than 5 Years from Alzheimer�s Disease-Modifying Drugs,� - Accesswire

Fri, Sep 10, 2010

11:18 AM

Big player at Wyeth and Pfizer joins ILNS as Alzheimer's pipeline draws attention - Accesswire

Fri, Aug 20, 2010

12:36 PM

Intellect Neurosciences' search for Alzheimer's treatment continues without doubts - Accesswire

12:36 PM

Intellect Neurosciences' search for Alzheimer's treatment continues without doubts - Accesswire

Thu, Jul 15, 2010

11:35 AM

Another step forward in the fight against Alzheimer's ? - Accesswire

9:50 AM

Experimental Alzheimer's drug being developed by Big Pharma may help micro-cap stock - Accesswire

Wed, Jul 14, 2010

9:37 AM

News Media closly following Intellect Neurosciences - Accesswire

Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges). RT Realtime, RTx Real-Time ECN, EOD End Of Day, PD Previous Day. H Halted, r Restriction started today, r Restriction carried over from prior day . Market Data powered by QuoteMedia. Terms of Use.